Adverse Health Outcomes Among US Testicular Cancer Survivors After Cisplatin-Based Chemotherapy vs Surgical Management

We evaluated for the first time, to our knowledge, adverse health outcomes (AHOs) among US testicular cancer survivors (TCS) given chemotherapy (n = 381) vs surgery-only patients (n = 98) managed at a single institution, accounting for non-treatment-related risk factors to delineate chemotherapy’s i...

Descripción completa

Detalles Bibliográficos
Autores principales: Agrawal, Vaibhav, Dinh, Paul C, Fung, Chunkit, Monahan, Patrick O, Althouse, Sandra K, Norton, Kelli, Cary, Clint, Einhorn, Lawrence, Fossa, Sophie D, Adra, Nabil, Travis, Lois B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065712/
https://www.ncbi.nlm.nih.gov/pubmed/32190815
http://dx.doi.org/10.1093/jncics/pkz079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065712/
https://www.ncbi.nlm.nih.gov/pubmed/32190815
http://dx.doi.org/10.1093/jncics/pkz079

Ejemplares similares